Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01100424 · ClinicalTrials.gov registry record · NA
Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining
A NA study of Corneal Staining, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT01100424 is a NA study of Corneal Staining that has completed, run by Alcon Research. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01100424, a NA study of Corneal Staining, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to investigate the association of inflammatory mediators found in the tear film during the development and following the induction of contact lens solution-induced corneal staining.
Conditions Studied
Interventions
- DEVICE Opti-Free RepleniSH
- DEVICE ReNu MultiPlus
- DEVICE Balafilcon A
- OTHER Unisol 4
Study Locations (1)
Texas
- Contact Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01100424
The ClinicalTrials.gov registry entry for NCT01100424 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Corneal Staining appearing as the primary indexed condition, and to 4 interventions - of which Opti-Free RepleniSH is the first listed.
NCT01100424 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01100424 about?
NCT01100424 is a clinical study titled "Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining". The purpose of this study was to investigate the association of inflammatory mediators found in the tear film during the development and following the induction of contact lens solution-induced corneal staining.
What is the current status of trial NCT01100424?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2010-03. Estimated completion is 2010-09.
What conditions does trial NCT01100424 study?
This clinical trial studies the following conditions: Corneal Staining.
What interventions are being tested in trial NCT01100424?
The interventions under investigation include: Opti-Free RepleniSH (DEVICE), ReNu MultiPlus (DEVICE), Balafilcon A (DEVICE), Unisol 4 (OTHER).
Who is sponsoring clinical trial NCT01100424?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01100424 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.